NCT05616884 is a NA clinical trial of Cementless fixation in Partial Knee Replacement, sponsored by Anderson Orthopaedic Research Institute.

Who is sponsoring NCT05616884?

NCT05616884 is sponsored by Anderson Orthopaedic Research Institute.

What drugs are being tested in NCT05616884?

Interventions in NCT05616884: Cementless fixation.

What condition does NCT05616884 study?

NCT05616884 studies Partial Knee Replacement.

Is NCT05616884 still recruiting?

NCT05616884 is currently enrolling by invitation. Last updated 24 July 2023.

Last reviewed 2023-07-24 · How we verify

NCT05616884

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Cemented vs. Cementless Unicompartmental Knee Arthroplasty

ENROLLING BY INVITATION NA Last updated 24 July 2023

What this trial tests

NA trial testing Cementless fixation in Partial Knee Replacement in 100 participants. Enrolling by invitation.

Timeline

8 July 2022

Primary endpoint
30 December 2025

30 December 2026

Quick facts

Lead sponsor	Anderson Orthopaedic Research Institute
Phase	NA
Status	ENROLLING BY INVITATION
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	100
Start date	8 July 2022
Primary completion	30 December 2025
Estimated completion	30 December 2026
Sites	1 location across United States

Drugs / interventions tested

Cementless fixation

Conditions studied

Partial Knee Replacement — all drugs for Partial Knee Replacement →

Sponsor

Anderson Orthopaedic Research Institute

Who can join

Adults 18 to 85, any sex, with Partial Knee Replacement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary study objective is to evaluate a cementless partial knee system that has a modular 3-D printed porous metal tibial component and a cemented partial knee system. The hypothesis is that at minimum 2-year follow-up, fixed bearing medial partial knee replacements using cementless and cemented fixation will demonstrate no differences in clinical outcome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Anderson Orthopaedic Research Institute trials

Trials by the same sponsor.

NCT02508428 — Marathon and Enduron Polyethylene at Long-Term Follow-up · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05616884 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Anderson Orthopaedic Research Institute
Last refreshed: 24 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05616884.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing